PEGylated Biopharmaceuticals: Current Experience and Considerations for Nonclinical Development.
Ivens IA, Achanzar W, Baumann A, Brändli-Baiocco A, Cavagnaro J, Dempster M, Depelchin BO, Rovira AR, Dill-Morton L, Lane JH, Reipert BM, Salcedo T, Schweighardt B, Tsuruda LS, Turecek PL, Sims J.
Ivens IA, et al. Among authors: schweighardt b.
Toxicol Pathol. 2015 Oct;43(7):959-83. doi: 10.1177/0192623315591171. Epub 2015 Aug 3.
Toxicol Pathol. 2015.
PMID: 26239651
Review.